Disease | thrombocytopenia |
Phenotype | C0685938|gastrointestinal cancer |
Sentences | 1 |
PubMedID- 25702890 | Previous studies have demonstrated that a peptide-based il-11 antagonist is well tolerated with no thrombocytopenia in gastrointestinal cancer.18 moreover, anti-il-6 antibody has been used in clinical trials for lymphoma, rcc and ovarian cancer.24–26 here, our findings showed that the high expression of il-11 was associated with tumor progression and poor outcome in ccrcc patients. |
Page: 1